Form 4: USANA Health Sciences Inc. Executive Joshua Foukas Reports Sale of Common Stock
SEC Form 4 Filing
Joshua Foukas, Chief Legal Officer of USANA Health Sciences Inc., reported the sale of 4,847 shares of common stock on February 29, 2024.
Summary
- On February 29, 2024, Joshua Foukas, the Chief Legal Officer of USANA Health Sciences Inc., sold 4,847 shares of the company's common stock.
- The sale was executed at a weighted average price of $47.913 per share.
- The price range for the multiple transactions was between $47.84 and $48.12 inclusively.
- Following the transaction, Foukas directly owns 0 shares of USANA Health Sciences Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by an executive, with no inherent positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when an officer of a publicly traded company buys or sells shares in their company. It provides transparency to investors regarding insider transactions.
Stakeholder Impact
- The sale of shares by an executive may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of the transaction: sale of common stock. |
| 03/04/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.